
1. j biol chem. 2007 apr 20;282(16):12048-57. epub 2007 feb 21.

the werner syndrome helicase cofactor hiv-1 long terminal repeat
transactivation retroviral replication.

sharma a(1), awasthi s, harrod ck, matlock ef, khan s, xu l, chan s, yang h,
thammavaram ck, rasor ra, burns dk, skiest dj, van lint c, girard am, mcgee m,
monnat rj jr, harrod r.

author information: 
(1)laboratory molecular virology, department biological sciences, southern 
methodist university, dallas, texas 75275-0376, usa.

the werner syndrome helicase (wrn) participates dna replication, double strand
break repair, telomere maintenance, p53 activation. mutations wrn cause
werner syndrome (ws), autosomal recessive premature aging disorder associated 
with cancer predisposition, atherosclerosis, aging related symptoms.
here, report wrn novel cofactor hiv-1 replication. immortalized 
human wrn(-/-) ws fibroblasts, lacking functional wrn gene, impaired for
basal tat-activated hiv-1 transcription. overexpression wild-type wrn
transactivates hiv-1 long terminal repeat (ltr) absence tat, and
wrn cooperates tat promote high-level ltr transactivation. ectopic wrn
induces hiv-1 p24(gag) production retroviral replication hiv-1-infected
h9(hiv-1iiib) lymphocytes. dominant-negative helicase-minus mutant, wrn(k577m),
inhibits ltr transactivation hiv-1 replication. inhibition endogenous wrn,
through co-expression wrn(k577m), diminishes recruitment p300/creb-binding 
protein-associated factor (pcaf) positive transcription elongation factor b
(p-tefb) tat/transactivation response-rna complexes, immortalized wrn(-/-)
ws fibroblasts exhibit comparable defects recruitment pcaf p-tefb to
the hiv-1 ltr. results demonstrate wrn novel cellular cofactor 
hiv-1 replication suggest wrn helicase participates the
recruitment pcaf/p-tefb-containing transcription complexes. wrn may a
plausible target antiretroviral therapy.

doi: 10.1074/jbc.m608104200 
pmid: 17317667  [indexed medline]

